ATE109001T1 - Mittel zur stimulierung der tränensekretion. - Google Patents

Mittel zur stimulierung der tränensekretion.

Info

Publication number
ATE109001T1
ATE109001T1 AT89904439T AT89904439T ATE109001T1 AT E109001 T1 ATE109001 T1 AT E109001T1 AT 89904439 T AT89904439 T AT 89904439T AT 89904439 T AT89904439 T AT 89904439T AT E109001 T1 ATE109001 T1 AT E109001T1
Authority
AT
Austria
Prior art keywords
agents
tear secretion
stimulating tear
stimulating
secretion
Prior art date
Application number
AT89904439T
Other languages
English (en)
Inventor
Ronald D Schoenwald
Charles F Barfknecht
Original Assignee
Univ Iowa Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Iowa Res Found filed Critical Univ Iowa Res Found
Application granted granted Critical
Publication of ATE109001T1 publication Critical patent/ATE109001T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
AT89904439T 1988-03-16 1989-03-13 Mittel zur stimulierung der tränensekretion. ATE109001T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/168,680 US4820737A (en) 1987-02-17 1988-03-16 Lacrimal secretion stimulant (lss)

Publications (1)

Publication Number Publication Date
ATE109001T1 true ATE109001T1 (de) 1994-08-15

Family

ID=22612490

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89904439T ATE109001T1 (de) 1988-03-16 1989-03-13 Mittel zur stimulierung der tränensekretion.

Country Status (9)

Country Link
US (1) US4820737A (de)
EP (1) EP0363469B1 (de)
JP (1) JP2929384B2 (de)
KR (1) KR0135634B1 (de)
AT (1) ATE109001T1 (de)
AU (2) AU611021B2 (de)
CA (1) CA1328665C (de)
DE (1) DE68917071T2 (de)
WO (1) WO1989008452A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256698A (en) * 1987-02-17 1993-10-26 University Of Iowa Research Foundation Treatment of psychosis using cyclohexyl-phenyl-lower alkyl amine derivatives
US5192535A (en) * 1988-02-08 1993-03-09 Insite Vision Incorporated Ophthalmic suspensions
US5188826A (en) * 1988-02-08 1993-02-23 Insite Vision Incorporated Topical ophthalmic suspensions
US5124154A (en) * 1990-06-12 1992-06-23 Insite Vision Incorporated Aminosteroids for ophthalmic use
WO1992017175A1 (en) * 1991-03-29 1992-10-15 University Of Iowa Research Foundation Ophthalmic uses of sigma site binders
US5225424A (en) * 1992-10-21 1993-07-06 University Of Iowa Research Foundation Methazolamide-derived carbonic anhydrase inhibitors
AU6124494A (en) * 1993-01-28 1994-08-15 University Of Iowa Research Foundation, The Ophthalmic uses of signa agonists
US5322859A (en) * 1993-02-08 1994-06-21 University Of Iowa Research Foundation Antiglaucoma drug composition and method
US5340572A (en) * 1993-02-08 1994-08-23 Insite Vision Incorporated Alkaline ophthalmic suspensions
US5387614A (en) * 1993-07-27 1995-02-07 University Of Iowa Research Foundation Use of sigma receptor ligands as salivary gland stimulants
US5961987A (en) * 1996-10-31 1999-10-05 University Of Iowa Research Foundation Ocular protein stimulants
US8173709B2 (en) * 1999-09-22 2012-05-08 Quadex Pharmaceuticals, Llc Anti-infective methods for treating pathogen-induced disordered tissues
US6759434B2 (en) 1999-09-22 2004-07-06 B. Ron Johnson Anti-infective compositions, methods and systems for treating disordered tissue
US20060073172A1 (en) * 2004-10-01 2006-04-06 Schneider L W Stabilized ophthalmic solution for the treatment of glaucoma and lowering intraocular pressure
US8143254B2 (en) * 2005-02-18 2012-03-27 Cornell Research Foundation, Inc. Methods for modulating ion channels
US9482677B2 (en) 2008-02-27 2016-11-01 Scios Inc. Method, composition and device for sampling natriuretic peptides in a biological fluid
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4289787A (en) * 1977-12-19 1981-09-15 Eli Lilly And Company Quaternary ammonium antiarrhythmic drugs
US4409205A (en) * 1979-03-05 1983-10-11 Cooper Laboratories, Inc. Ophthalmic solution
US4407792A (en) * 1979-05-09 1983-10-04 Alcon Laboratories, Inc. Sustained release ophthalmic drug dosage

Also Published As

Publication number Publication date
EP0363469A4 (en) 1991-05-15
US4820737A (en) 1989-04-11
JP2929384B2 (ja) 1999-08-03
CA1328665C (en) 1994-04-19
DE68917071T2 (de) 1994-12-01
EP0363469B1 (de) 1994-07-27
DE68917071D1 (de) 1994-09-01
JPH02503442A (ja) 1990-10-18
WO1989008452A1 (en) 1989-09-21
EP0363469A1 (de) 1990-04-18
KR900700091A (ko) 1990-08-11
KR0135634B1 (ko) 1998-04-23
AU611021B2 (en) 1991-05-30
AU3414289A (en) 1989-10-05
AU8351491A (en) 1991-11-14

Similar Documents

Publication Publication Date Title
DE68917071D1 (de) Mittel zur stimulierung der tränensekretion.
ATE411026T1 (de) Mittel zur behandlung der alzheimer-krankheit
ES482778A0 (es) Un procedimiento para la preparacion de una composicion u- til en el tratamiento de la epidermis.
SE7903186L (sv) Cerebralverksamt medel
NO831084L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kvartaere dibenzotiepin-n-alkyl-norskopinetere
DE69019774D1 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
FR2342072A1 (fr) Composition enzymatique pour le traitement de la cataracte
ES2154262T3 (es) Uso de compuestos macrolidos para enfermedades oculares.
FI895064A7 (fi) Syklosporiinia sisältäviä koostumuksia silmätulehdusten hoitoon
FI915093A0 (fi) Sackarinderivat anvaendbara som inhibitorer foer proteolytiskt enzym och deras framstaellning.
TR200400526T4 (tr) Göz kurumasının tedavisi için lipoksin A4 ve analogları
ES2087160T3 (es) Composiciones y procedimiento para el tratamiento de trastornos dolorosos, inflamatorios o alergicos.
KR900701323A (ko) 신규한 녹내장 치료용 안과 제제
ATE162074T1 (de) Oculare hypotensive mittel
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
ATE68182T1 (de) Thiophensulfonamide zur behandlung von glaukom.
ES2079068T3 (es) 2-amino-6-fenil-4h-piran-4-onas antiateroscleroticas y antitromboticas.
FI951511A0 (fi) IL-10:n käyttö insuliinista riippuvan diabetes mellituksen ennaltaestoon tai hoitoon
ATE106736T1 (de) Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
NO891894D0 (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
FI873429A7 (fi) Silmälääketieteelliset koostumukset hermodegeneraatioiden hoitoon.
ES2044170T3 (es) Sal de estroncio, su procedimiento de preparacion y las composiciones farmaceuticas que la contienen.
ES2083636T3 (es) Componente adhesivo para la restauracion de la sustancia dental dura.
ES2014494B3 (es) Procedimiento para el tratamiento de material de fibra de celulosa coloreada
NO890801D0 (no) Fremgangsmaate for fremstilling av lysyloxydaseinhibitorer.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee